Dr. Raymond Manho Yau, MD

Dr. Yau practices at Lovelace Medical Center in Albuquerque, New Mexico, part of Ardent Health.

Dr. Yau's NPI, 1497932503, was assigned on January 31, 2008. Dr. Yau graduated from University of California, Davis School of Medicine in 2007. Dr. Yau holds New Mexico license MD2014-0586.

Dr. Yau's primary practice is Lovelace Medical Center, at 601 Dr Martin Luther King Jr Ave NE, Albuquerque, NM 87102 in Bernalillo County. The practice phone is (505) 727-8000.

Dr. Yau's primary practice is Lovelace Medical Center in Albuquerque, New Mexico, part of Ardent Health. Dr. Yau is also affiliated with Presbyterian Hospital. The medical group on file is Lovelace Medical Group. Dmand AI also links Dr. Yau to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yau practices, 7 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Yau's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Yau is licensed in New Mexico.

CMS data shows 2,296 Medicare services from Dr. Yau across 22 procedure codes in 2024, for 557 Medicare patients. Medicare paid $180,342 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 557 Medicare patients who saw Dr. Yau in 2024. The largest group is 65 to 74, with 251 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yau's median patient age at 76, with 37% women.

In 2024, Dr. Yau wrote 5,648 Medicare Part D claims for 630 patients. 79% of them were for generic drugs. CMS names the drug for 5,393 of them, across 38 drugs with 11 or more claims each, at $1,089,633 in total drug cost. In 2023, CMS named 4,576 claims across 38 drugs.

Dr. Yau accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yau as offering telehealth. CMS counts 77 procedures of coronary angioplasty and stenting by Dr. Yau, more than 93% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Yau in 2024. Dr. Yau's most frequent co-authors are Jacob Abraham, MD, Aasim M. Afzal, MD and Mir Babar Basir, DO.

Dmand AI links Dr. Yau to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Coronary Artery Disease, Inferior Wall Myocardial Infarction and Anterior Wall Myocardial Infarction.

CMS Open Payments shows 1,242 general payments to Dr. Yau from 40 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 25% of the total. Abiomed paid the most, $94,590. It also lists 6 research payments totaling $408 in 2023.

Dr. Yau graduated from University of California, Davis School of Medicine in 2007.